Oragenics, Inc. Form 8-K Summary
Business Context and Reporting Period
Oragenics, Inc. filed this Current Report on Form 8-K on March 20, 2019. The filing primarily announces a proposed underwritten public offering and provides preliminary unaudited financial results for the fiscal year ended December 31, 2018.
Key Financial Metrics
| Metric | Value (FY 2018) | Value (FY 2017) |
|---|---|---|
| Net Cash Used in Operating Activities | $9,079,817 (Estimated) | $6,363,853 |
| Cash and Cash Equivalents (as of Dec 31, 2018) | $20,208,301 (Estimated) | N/A |
| Revenue, Profit, and Margins | Not provided in this filing | |
| Debt | Not provided in this filing |
Material Changes
- Operating Cash Flow: Net cash used in operating activities increased by approximately $2.72 million, rising from $6.36 million in 2017 to an estimated $9.08 million in 2018.
- Liquidity: The company reported an estimated cash balance of approximately $20.21 million as of December 31, 2018.
Guidance, Outlook, and Risks
Capital Raise: The company announced a proposed underwritten public offering on March 20, 2019, with details available in the attached press release (Exhibit 99.1).
Data Reliability: The financial data presented is preliminary and based on management estimates. The company's auditor has not audited, reviewed, or performed any procedures on this data. Actual results may differ following the completion of the financial audit.
Risks: Investors are advised to review the company's most recent Form 10-K and Form 10-Q filings for comprehensive financial statements and risk factors.
Investor Verification Checklist
- Verify the final audited financial results for the fiscal year ended December 31, 2018, once the audit is complete.
- Review the attached press release (Exhibit 99.1) for specific terms of the proposed underwritten public offering.
- Examine the most recent Form 10-K and Form 10-Q for detailed revenue, profit, and debt information not included in this summary.
- Confirm the final cash balance and liquidity position in the upcoming audited annual report.